{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:31:16Z","timestamp":1792020676723,"version":"4.4.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Agencia de Gesti\u00f3n de Ayudas Universitarias y de Investigaci\u00f3n de Catalunya","award":["SGR 01324 Q5856414G"],"award-info":[{"award-number":["SGR 01324 Q5856414G"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pneumonia"],"DOI":"10.1186\/s41479-025-00189-5","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:02:29Z","timestamp":1767571349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Invasive pulmonary aspergillosis in the ICU: the corticosteroid link"],"prefix":"10.1186","volume":"18","author":[{"given":"Cynthia","family":"Terrones-Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gallardo-Pizarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Martinez-Urrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainhoa","family":"Castiella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azucena","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Egri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Garcia-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"189_CR1","doi-asserted-by":"publisher","unstructured":"Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi (Basel) Oct. 2017;18(4). https:\/\/doi.org\/10.3390\/jof3040057.","DOI":"10.3390\/jof3040057"},{"key":"189_CR2","doi-asserted-by":"publisher","unstructured":"Monzo-Gallo P, Chumbita M, Lopera C, et al. Real-life epidemiology and current outcomes of hospitalized adults with invasive fungal infections. Med Mycol Mar. 2023;2(3). https:\/\/doi.org\/10.1093\/mmy\/myad021.","DOI":"10.1093\/mmy\/myad021"},{"issue":"4","key":"189_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/QCO.0000000000000662","volume":"33","author":"NP Wiederhold","year":"2020","unstructured":"Wiederhold NP, Verweij PE. Aspergillus fumigatus and pan-azole resistance: who should be concerned? Curr Opin Infect Dis Aug. 2020;33(4):290\u20137. https:\/\/doi.org\/10.1097\/QCO.0000000000000662.","journal-title":"Curr Opin Infect Dis Aug"},{"key":"189_CR4","doi-asserted-by":"publisher","unstructured":"Kluge S, Strauss R, Kochanek M, Weigand MA, Rohde H, Lahmer T, Aspergillosis. Emerging risk groups in critically ill patients. Med Mycol Dec. 2021;8(1). https:\/\/doi.org\/10.1093\/mmy\/myab064.","DOI":"10.1093\/mmy\/myab064"},{"issue":"6","key":"189_CR5","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","volume":"15","author":"W Meersseman","year":"2004","unstructured":"Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med Sep. 2004;15(6):621\u20135. https:\/\/doi.org\/10.1164\/rccm.200401-093OC.","journal-title":"Am J Respir Crit Care Med Sep"},{"issue":"3","key":"189_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00428-006-0364-5","volume":"450","author":"C Maris","year":"2007","unstructured":"Maris C, Martin B, Creteur J, et al. Comparison of clinical and post-mortem findings in intensive care unit patients. Virchows Arch Mar. 2007;450(3):329\u201333. https:\/\/doi.org\/10.1007\/s00428-006-0364-5.","journal-title":"Virchows Arch Mar"},{"issue":"5","key":"189_CR7","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1016\/S1473-3099(24)00103-8","volume":"24","author":"DW Denning","year":"2024","unstructured":"Denning DW. Global incidence and mortality of severe fungal disease - Author\u2019s reply. Lancet Infect Dis May. 2024;24(5):e269. https:\/\/doi.org\/10.1016\/S1473-3099(24)00103-8.","journal-title":"Lancet Infect Dis May"},{"issue":"8","key":"189_CR8","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1086\/591969","volume":"15","author":"C Garcia-Vidal","year":"2008","unstructured":"Garcia-Vidal C, Upton A, Kirby KA, Marr KA. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis Oct. 2008;15(8):1041\u201350. https:\/\/doi.org\/10.1086\/591969.","journal-title":"Clin Infect Dis Oct"},{"key":"189_CR9","doi-asserted-by":"publisher","unstructured":"Nucci M, Anaissie E. Jun. Fungal infections in hematopoietic stem cell transplantation and solid-organ transplantation\u2013focus on aspergillosis. Clin Chest Med. 2009;30(2):295\u2013306, vii. https:\/\/doi.org\/10.1016\/j.ccm.2009.03.001","DOI":"10.1016\/j.ccm.2009.03.001"},{"issue":"2","key":"189_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1086\/518852","volume":"15","author":"W Meersseman","year":"2007","unstructured":"Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E. Invasive aspergillosis in the intensive care unit. Clin Infect Dis Jul. 2007;15(2):205\u201316. https:\/\/doi.org\/10.1086\/518852.","journal-title":"Clin Infect Dis Jul"},{"issue":"8","key":"189_CR11","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1093\/jac\/dks155","volume":"67","author":"M Hoenigl","year":"2012","unstructured":"Hoenigl M, Strenger V, Buzina W, et al. European organization for the research and treatment of Cancer\/Mycoses study group (EORTC\/MSG) host factors and invasive fungal infections in patients with haematological malignancies. J Antimicrob Chemother Aug. 2012;67(8):2029\u201333. https:\/\/doi.org\/10.1093\/jac\/dks155.","journal-title":"J Antimicrob Chemother Aug"},{"issue":"Suppl 1","key":"189_CR12","doi-asserted-by":"publisher","first-page":"S124","DOI":"10.1007\/s001340051129","volume":"26","author":"WJ Kox","year":"2000","unstructured":"Kox WJ, Volk T, Kox SN, Volk HD. Immunomodulatory therapies in sepsis. Intensive Care Med. 2000;26(Suppl 1):S124\u20138. https:\/\/doi.org\/10.1007\/s001340051129.","journal-title":"Intensive Care Med"},{"issue":"11","key":"189_CR13","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1007\/s00134-003-1778-z","volume":"29","author":"KJ Hartemink","year":"2003","unstructured":"Hartemink KJ, Paul MA, Spijkstra JJ, Girbes AR, Polderman KH. Immunoparalysis as a cause for invasive aspergillosis? Intensive Care Med Nov. 2003;29(11):2068\u201371. https:\/\/doi.org\/10.1007\/s00134-003-1778-z.","journal-title":"Intensive Care Med Nov"},{"issue":"1","key":"189_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/thx.46.1.15","volume":"46","author":"LB Palmer","year":"1991","unstructured":"Palmer LB, Greenberg HE, Schiff MJ. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax Jan. 1991;46(1):15\u201320. https:\/\/doi.org\/10.1136\/thx.46.1.15.","journal-title":"Thorax Jan"},{"issue":"4","key":"189_CR15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.riam.2014.07.004","volume":"31","author":"J Barberan","year":"2014","unstructured":"Barberan J, Mensa J. [Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease]. Rev Iberoam Micol Oct-Dec. 2014;31(4):237\u201341. https:\/\/doi.org\/10.1016\/j.riam.2014.07.004. Aspergilosis pulmonar invasiva en el enfermo con enfermedad pulmonar obstructiva cronica.","journal-title":"Rev Iberoam Micol Oct-Dec"},{"issue":"7","key":"189_CR16","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/j.1469-0691.2009.03015.x","volume":"16","author":"J Guinea","year":"2010","unstructured":"Guinea J, Torres-Narbona M, Gijon P, et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect Jul. 2010;16(7):870\u20137. https:\/\/doi.org\/10.1111\/j.1469-0691.2009.03015.x.","journal-title":"Clin Microbiol Infect Jul"},{"key":"189_CR17","doi-asserted-by":"publisher","unstructured":"Schauwvlieghe A, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. Oct 2018;6(10):782\u201392. https:\/\/doi.org\/10.1016\/S2213-2600(18)30274-1.","DOI":"10.1016\/S2213-2600(18)30274-1"},{"issue":"1","key":"189_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.37201\/req\/s01.21.2021","volume":"34","author":"M Chumbita","year":"2021","unstructured":"Chumbita M, Puerta-Alcalde P, Garcia-Pouton N, Garcia-Vidal C. COVID-19 and fungal infections: etiopathogenesis and therapeutic implications. Rev Esp Quimioter Sep. 2021;34(1):72\u20135. https:\/\/doi.org\/10.37201\/req\/s01.21.2021.","journal-title":"Rev Esp Quimioter Sep"},{"issue":"4","key":"189_CR19","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3201\/eid2704.204895","volume":"27","author":"J Salmanton-Garcia","year":"2021","unstructured":"Salmanton-Garcia J, Sprute R, Stemler J, et al. COVID-19-Associated pulmonary Aspergillosis, March-August 2020. Emerg Infect Dis. 2021;27(4):1077\u201386. https:\/\/doi.org\/10.3201\/eid2704.204895.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"189_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3201\/eid2701.202896","volume":"27","author":"KA Marr","year":"2021","unstructured":"Marr KA, Platt A, Tornheim JA, et al. Aspergillosis complicating severe coronavirus disease. Emerg Infect Dis Jan. 2021;27(1):18\u201325. https:\/\/doi.org\/10.3201\/eid2701.202896.","journal-title":"Emerg Infect Dis Jan"},{"issue":"6","key":"189_CR21","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1093\/cid\/cir485","volume":"53","author":"C Garcia-Vidal","year":"2011","unstructured":"Garcia-Vidal C, Barba P, Arnan M, et al. Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients. Clin Infect Dis Sep. 2011;53(6):e16\u20139. https:\/\/doi.org\/10.1093\/cid\/cir485.","journal-title":"Clin Infect Dis Sep"},{"issue":"8","key":"189_CR22","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","volume":"7","author":"M Hoenigl","year":"2022","unstructured":"Hoenigl M, Seidel D, Sprute R, et al. COVID-19-associated fungal infections. Nat Microbiol Aug. 2022;7(8):1127\u201340. https:\/\/doi.org\/10.1038\/s41564-022-01172-2.","journal-title":"Nat Microbiol Aug"},{"issue":"4","key":"189_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jinf.2014.03.018","volume":"69","author":"M Peghin","year":"2014","unstructured":"Peghin M, Ruiz-Camps I, Garcia-Vidal C, et al. Unusual forms of subacute invasive pulmonary aspergillosis in patients with solid tumors. J Infect Oct. 2014;69(4):387\u201395. https:\/\/doi.org\/10.1016\/j.jinf.2014.03.018.","journal-title":"J Infect Oct"},{"issue":"6","key":"189_CR24","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.ccell.2017.05.004","volume":"12","author":"C Grommes","year":"2017","unstructured":"Grommes C, Younes A. Ibrutinib in PCNSL: the curious cases of clinical responses and aspergillosis. Cancer Cell Jun. 2017;12(6):731\u20133. https:\/\/doi.org\/10.1016\/j.ccell.2017.05.004.","journal-title":"Cancer Cell Jun"},{"issue":"1","key":"189_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/cid\/cix687","volume":"6","author":"G Chamilos","year":"2018","unstructured":"Chamilos G, Lionakis MS, Kontoyiannis DP. Call for action: invasive fungal infections associated with ibrutinib and other small molecule kinase inhibitors targeting immune signaling pathways. Clin Infect Dis Jan. 2018;6(1):140\u20138. https:\/\/doi.org\/10.1093\/cid\/cix687.","journal-title":"Clin Infect Dis Jan"},{"issue":"11","key":"189_CR26","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/mmy\/myab044","volume":"3","author":"N Verma","year":"2021","unstructured":"Verma N, Singh S, Syal A, Pradhan P, Singh M, Singh M. Invasive aspergillosis is a critical determinant of mortality in cirrhosis: a systematic review with meta-analysis. Med Mycol Nov. 2021;3(11):1092\u2013100. https:\/\/doi.org\/10.1093\/mmy\/myab044.","journal-title":"Med Mycol Nov"},{"issue":"5","key":"189_CR27","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1164\/rccm.201910-1931OC","volume":"1","author":"R Nyga","year":"2020","unstructured":"Nyga R, Maizel J, Nseir S, et al. Invasive tracheobronchial aspergillosis in critically ill patients with severe Influenza. A clinical trial. Am J Respir Crit Care Med. Sep 2020;1(5):708\u201316. https:\/\/doi.org\/10.1164\/rccm.201910-1931OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"189_CR28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1128\/CMR.00055-08","volume":"22","author":"TR Dagenais","year":"2009","unstructured":"Dagenais TR, Keller NP. Pathogenesis of Aspergillus fumigatus in invasive aspergillosis. Clin Microbiol Rev Jul. 2009;22(3):447\u201365. https:\/\/doi.org\/10.1128\/CMR.00055-08.","journal-title":"Clin Microbiol Rev Jul"},{"issue":"3","key":"189_CR29","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1172\/jci110489","volume":"69","author":"A Schaffner","year":"1982","unstructured":"Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest Mar. 1982;69(3):617\u201331. https:\/\/doi.org\/10.1172\/jci110489.","journal-title":"J Clin Invest Mar"},{"issue":"3","key":"189_CR30","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/QCO.0b013e32835fb920","volume":"26","author":"C Garcia-Vidal","year":"2013","unstructured":"Garcia-Vidal C, Viasus D, Carratala J. Pathogenesis of invasive fungal infections. Curr Opin Infect Dis Jun. 2013;26(3):270\u20136. https:\/\/doi.org\/10.1097\/QCO.0b013e32835fb920.","journal-title":"Curr Opin Infect Dis Jun"},{"issue":"4","key":"189_CR31","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.riam.2014.09.001","volume":"31","author":"C Garcia-Vidal","year":"2014","unstructured":"Garcia-Vidal C, Salavert Lleti M. [Immunopathogenesis of invasive mould infections]. Rev Iberoam Micol. Oct-Dec. 2014;31(4):219\u201328. https:\/\/doi.org\/10.1016\/j.riam.2014.09.001. Inmunopatologia de las micosis invasivas por hongos filamentosos.","journal-title":"Oct-Dec"},{"issue":"3","key":"189_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.eimc.2011.09.011","volume":"30","author":"C Garcia-Vidal","year":"2012","unstructured":"Garcia-Vidal C, Carratala J. [Pathogenesis of invasive fungal infections]. Enferm Infecc Microbiol Clin Mar. 2012;30(3):151\u20138. https:\/\/doi.org\/10.1016\/j.eimc.2011.09.011. Patogenia de la infeccion fungica invasora.","journal-title":"Enferm Infecc Microbiol Clin Mar"},{"issue":"5","key":"189_CR33","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1056\/NEJMoa1211161","volume":"30","author":"C Cunha","year":"2014","unstructured":"Cunha C, Aversa F, Lacerda JF, et al. Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation. N Engl J Med Jan. 2014;30(5):421\u201332. https:\/\/doi.org\/10.1056\/NEJMoa1211161.","journal-title":"N Engl J Med Jan"},{"key":"189_CR34","doi-asserted-by":"publisher","unstructured":"Fisher CE, Hohl TM, Fan W et al. Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation. Blood. May 11. 2017;129(19):2693\u20132701. https:\/\/doi.org\/10.1182\/blood-2016-10-743294","DOI":"10.1182\/blood-2016-10-743294"},{"issue":"35","key":"189_CR35","doi-asserted-by":"publisher","first-page":"30393","DOI":"10.1074\/jbc.M111.266528","volume":"2","author":"H Fang","year":"2011","unstructured":"Fang H, Wu Y, Huang X, et al. Toll-like receptor 4 (TLR4) is essential for Hsp70-like protein 1 (HSP70L1) to activate dendritic cells and induce Th1 response. J Biol Chem Sep. 2011;2(35):30393\u2013400. https:\/\/doi.org\/10.1074\/jbc.M111.266528.","journal-title":"J Biol Chem Sep"},{"issue":"40","key":"189_CR36","doi-asserted-by":"publisher","first-page":"37692","DOI":"10.1074\/jbc.M105927200","volume":"5","author":"F Re","year":"2001","unstructured":"Re F, Strominger JL. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem Oct. 2001;5(40):37692\u20139. https:\/\/doi.org\/10.1074\/jbc.M105927200.","journal-title":"J Biol Chem Oct"},{"issue":"9","key":"189_CR37","doi-asserted-by":"publisher","first-page":"e44266","DOI":"10.1371\/journal.pone.0044266","volume":"7","author":"FS Lichtenegger","year":"2012","unstructured":"Lichtenegger FS, Mueller K, Otte B, et al. CD86 and IL-12p70 are key players for T helper 1 polarization and natural killer cell activation by Toll-like receptor-induced dendritic cells. PLoS ONE. 2012;7(9):e44266. https:\/\/doi.org\/10.1371\/journal.pone.0044266.","journal-title":"PLoS ONE"},{"issue":"9","key":"189_CR38","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1182\/blood.v99.9.3427","volume":"1","author":"D Bosisio","year":"2002","unstructured":"Bosisio D, Polentarutti N, Sironi M, et al. Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood May. 2002;1(9):3427\u201331. https:\/\/doi.org\/10.1182\/blood.v99.9.3427.","journal-title":"Blood May"},{"issue":"9","key":"189_CR39","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.4049\/jimmunol.2001191","volume":"1","author":"N Gajanayaka","year":"2021","unstructured":"Gajanayaka N, Dong SXM, Ali H, et al. TLR-4 agonist induces IFN-gamma production selectively in Proinflammatory human M1 macrophages through the PI3K-mTOR- and JNK-MAPK-Activated p70S6K pathway. J Immunol Nov. 2021;1(9):2310\u201324. https:\/\/doi.org\/10.4049\/jimmunol.2001191.","journal-title":"J Immunol Nov"},{"key":"189_CR40","doi-asserted-by":"publisher","first-page":"1080153","DOI":"10.3389\/falgy.2022.1080153","volume":"3","author":"B Leon","year":"2022","unstructured":"Leon B. Understanding the development of Th2 cell-driven allergic airway disease in early life. Front Allergy. 2022;3:1080153. https:\/\/doi.org\/10.3389\/falgy.2022.1080153.","journal-title":"Front Allergy"},{"key":"189_CR41","doi-asserted-by":"publisher","unstructured":"Zelante T, Montagnoli C, Bozza S et al. Manipulating immunity against Aspergillus fumigatus. Med Mycol. Sep 1. 2006;44(Supplement_1):S237-S243. https:\/\/doi.org\/10.1080\/13693780600778668","DOI":"10.1080\/13693780600778668"},{"issue":"12","key":"189_CR42","doi-asserted-by":"publisher","first-page":"7614","DOI":"10.4049\/jimmunol.1002760","volume":"15","author":"PV Kasperkovitz","year":"2010","unstructured":"Kasperkovitz PV, Cardenas ML, Vyas JM. TLR9 is actively recruited to Aspergillus fumigatus phagosomes and requires the N-terminal proteolytic cleavage domain for proper intracellular trafficking. J Immunol Dec. 2010;15(12):7614\u201322. https:\/\/doi.org\/10.4049\/jimmunol.1002760.","journal-title":"J Immunol Dec"},{"issue":"1","key":"189_CR43","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1749-6632.2012.06837.x","volume":"1273","author":"MK Mansour","year":"2012","unstructured":"Mansour MK, Tam JM, Vyas JM. The cell biology of the innate immune response to Aspergillus fumigatus. Ann N Y Acad Sci Dec. 2012;1273(1):78\u201384. https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06837.x.","journal-title":"Ann N Y Acad Sci Dec"},{"issue":"5","key":"189_CR44","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1128\/IAI.00047-08","volume":"76","author":"ZG Ramirez-Ortiz","year":"2008","unstructured":"Ramirez-Ortiz ZG, Specht CA, Wang JP, et al. Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA. Infect Immun May. 2008;76(5):2123\u20139. https:\/\/doi.org\/10.1128\/IAI.00047-08.","journal-title":"Infect Immun May"},{"issue":"18","key":"189_CR45","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJMra0808853","volume":"30","author":"BH Segal","year":"2009","unstructured":"Segal BH, Aspergillosis. N Engl J Med Apr. 2009;30(18):1870\u201384. https:\/\/doi.org\/10.1056\/NEJMra0808853.","journal-title":"N Engl J Med Apr"},{"issue":"5","key":"189_CR46","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.4049\/jimmunol.1401545","volume":"196","author":"NS Khan","year":"2016","unstructured":"Khan NS, Kasperkovitz PV, Timmons AK, et al. Dectin-1 controls TLR9 trafficking to phagosomes containing beta-1,3 glucan. J Immunol Mar 1. 2016;196(5):2249\u201361. https:\/\/doi.org\/10.4049\/jimmunol.1401545.","journal-title":"J Immunol Mar 1"},{"issue":"1","key":"189_CR47","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1128\/IAI.00998-08","volume":"77","author":"H Ramaprakash","year":"2009","unstructured":"Ramaprakash H, Ito T, Standiford TJ, Kunkel SL, Hogaboam CM. Toll-like receptor 9 modulates immune responses to Aspergillus fumigatus conidia in immunodeficient and allergic mice. Infect Immun Jan. 2009;77(1):108\u201319. https:\/\/doi.org\/10.1128\/IAI.00998-08.","journal-title":"Infect Immun Jan"},{"issue":"3","key":"189_CR48","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1084\/jem.20020470","volume":"5","author":"GD Brown","year":"2002","unstructured":"Brown GD, Taylor PR, Reid DM, et al. Dectin-1 is a major beta-glucan receptor on macrophages. J Exp Med Aug. 2002;5(3):407\u201312. https:\/\/doi.org\/10.1084\/jem.20020470.","journal-title":"J Exp Med Aug"},{"issue":"Suppl 1","key":"189_CR49","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.3109\/13693786.2010.487077","volume":"49","author":"MJ Grimm","year":"2011","unstructured":"Grimm MJ, Vethanayagam RR, Almyroudis NG, et al. Role of NADPH oxidase in host defense against aspergillosis. Med Mycol Apr. 2011;49(Suppl 1):S144\u20139. https:\/\/doi.org\/10.3109\/13693786.2010.487077.","journal-title":"Med Mycol Apr"},{"key":"189_CR50","doi-asserted-by":"publisher","first-page":"830421","DOI":"10.1155\/2011\/830421","volume":"2011","author":"F Moalli","year":"2011","unstructured":"Moalli F, Jaillon S, Inforzato A, et al. Pathogen recognition by the long pentraxin PTX3. J Biomed Biotechnol. 2011;2011:830421. https:\/\/doi.org\/10.1155\/2011\/830421.","journal-title":"J Biomed Biotechnol"},{"issue":"13","key":"189_CR51","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1182\/blood-2002-01-0265","volume":"15","author":"H Hebart","year":"2002","unstructured":"Hebart H, Bollinger C, Fisch P, et al. Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies. Blood Dec. 2002;15(13):4521\u20138. https:\/\/doi.org\/10.1182\/blood-2002-01-0265.","journal-title":"Blood Dec"},{"issue":"7","key":"189_CR52","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3324\/haematol.2013.098830","volume":"99","author":"H Jolink","year":"2014","unstructured":"Jolink H, Hagedoorn RS, Lagendijk EL, et al. Induction of A. fumigatus-specific CD4-positive T cells in patients recovering from invasive aspergillosis. Haematologica Jul. 2014;99(7):1255\u201363. https:\/\/doi.org\/10.3324\/haematol.2013.098830.","journal-title":"Haematologica Jul"},{"key":"189_CR53","doi-asserted-by":"publisher","unstructured":"Thompson GR 3rd, Young JH. Aspergillus infections. N Engl J Med Oct. 2021;14(16):1496\u2013509. https:\/\/doi.org\/10.1056\/NEJMra2027424.","DOI":"10.1056\/NEJMra2027424"},{"issue":"11","key":"189_CR54","doi-asserted-by":"publisher","first-page":"5629","DOI":"10.4049\/jimmunol.1202601","volume":"1","author":"MS Gresnigt","year":"2013","unstructured":"Gresnigt MS, Becker KL, Smeekens SP, et al. Aspergillus fumigatus-induced IL-22 is not restricted to a specific Th cell subset and is dependent on complement receptor 3. J Immunol Jun. 2013;1(11):5629\u201339. https:\/\/doi.org\/10.4049\/jimmunol.1202601.","journal-title":"J Immunol Jun"},{"issue":"2","key":"189_CR55","doi-asserted-by":"publisher","first-page":"110763","DOI":"10.1016\/j.humimm.2024.110763","volume":"85","author":"A Nasiri-Jahrodi","year":"2024","unstructured":"Nasiri-Jahrodi A, Barati M, Namdar Ahmadabad H, Badali H, Morovati H. A comprehensive review on the role of T cell subsets and CAR-T cell therapy in Aspergillus fumigatus infection. Hum Immunol Mar. 2024;85(2):110763. https:\/\/doi.org\/10.1016\/j.humimm.2024.110763.","journal-title":"Hum Immunol Mar"},{"issue":"7","key":"189_CR56","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.4049\/jimmunol.1400776","volume":"1","author":"P Bacher","year":"2014","unstructured":"Bacher P, Kniemeyer O, Teutschbein J, et al. Identification of Immunogenic antigens from Aspergillus fumigatus by direct multiparameter characterization of specific conventional and regulatory CD4\u2009+\u2009T cells. J Immunol Oct. 2014;1(7):3332\u201343. https:\/\/doi.org\/10.4049\/jimmunol.1400776.","journal-title":"J Immunol Oct"},{"issue":"5","key":"189_CR57","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/infdis\/jit237","volume":"1","author":"H Jolink","year":"2013","unstructured":"Jolink H, Meijssen IC, Hagedoorn RS, et al. Characterization of the T-cell-mediated immune response against the Aspergillus fumigatus proteins Crf1 and catalase 1 in healthy individuals. J Infect Dis Sep. 2013;1(5):847\u201356. https:\/\/doi.org\/10.1093\/infdis\/jit237.","journal-title":"J Infect Dis Sep"},{"issue":"9","key":"189_CR58","doi-asserted-by":"publisher","first-page":"e74326","DOI":"10.1371\/journal.pone.0074326","volume":"8","author":"L Potenza","year":"2013","unstructured":"Potenza L, Vallerini D, Barozzi P, et al. Characterization of specific immune responses to different Aspergillus antigens during the course of invasive aspergillosis in hematologic patients. PLoS ONE. 2013;8(9):e74326. https:\/\/doi.org\/10.1371\/journal.pone.0074326.","journal-title":"PLoS ONE"},{"issue":"8","key":"189_CR59","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/infdis\/jiu607","volume":"15","author":"C Stuehler","year":"2015","unstructured":"Stuehler C, Nowakowska J, Bernardini C, et al. Multispecific Aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections. J Infect Dis Apr. 2015;15(8):1251\u201361. https:\/\/doi.org\/10.1093\/infdis\/jiu607.","journal-title":"J Infect Dis Apr"},{"issue":"1","key":"189_CR60","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1128\/IAI.73.1.494-503.2005","volume":"73","author":"V Balloy","year":"2005","unstructured":"Balloy V, Huerre M, Latge JP, Chignard M. Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect Immun Jan. 2005;73(1):494\u2013503. https:\/\/doi.org\/10.1128\/IAI.73.1.494-503.2005.","journal-title":"Infect Immun Jan"},{"issue":"9398","key":"189_CR61","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","volume":"29","author":"MS Lionakis","year":"2003","unstructured":"Lionakis MS, Kontoyiannis DP. Glucocorticoids and invasive fungal infections. Lancet Nov. 2003;29(9398):1828\u201338. https:\/\/doi.org\/10.1016\/S0140-6736(03)14904-5.","journal-title":"Lancet Nov"},{"issue":"Pt 9","key":"189_CR62","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1099\/13500872-140-9-2475","volume":"140","author":"TT Ng","year":"1994","unstructured":"Ng TT, Robson GD, Denning DW. Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis. Microbiology (Reading) Sep. 1994;140(Pt 9):2475\u20139. https:\/\/doi.org\/10.1099\/13500872-140-9-2475.","journal-title":"Microbiology (Reading) Sep"},{"issue":"4","key":"189_CR63","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1183\/09031936.00062206","volume":"30","author":"P Bulpa","year":"2007","unstructured":"Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J Oct. 2007;30(4):782\u2013800. https:\/\/doi.org\/10.1183\/09031936.00062206.","journal-title":"Eur Respir J Oct"},{"issue":"11","key":"189_CR64","doi-asserted-by":"publisher","first-page":"O939","DOI":"10.1111\/1469-0691.12650","volume":"20","author":"C Garcia-Vidal","year":"2014","unstructured":"Garcia-Vidal C, Royo-Cebrecos C, Peghin M, et al. Environmental variables associated with an increased risk of invasive aspergillosis. Clin Microbiol Infect Nov. 2014;20(11):O939\u201345. https:\/\/doi.org\/10.1111\/1469-0691.12650.","journal-title":"Clin Microbiol Infect Nov"},{"issue":"5","key":"189_CR65","doi-asserted-by":"publisher","first-page":"R167","DOI":"10.1186\/cc9259","volume":"14","author":"JF Bermejo-Martin","year":"2010","unstructured":"Bermejo-Martin JF, Martin-Loeches I, Rello J, et al. Host adaptive immunity deficiency in severe pandemic influenza. Crit Care. 2010;14(5):R167. https:\/\/doi.org\/10.1186\/cc9259.","journal-title":"Crit Care"},{"issue":"Suppl 2","key":"189_CR66","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","volume":"12","author":"M Bassetti","year":"2021","unstructured":"Bassetti M, Azoulay E, Kullberg BJ, et al. EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group. Clin Infect Dis Mar. 2021;12(Suppl 2):S121\u20137. https:\/\/doi.org\/10.1093\/cid\/ciaa1751.","journal-title":"Clin Infect Dis Mar"},{"key":"189_CR67","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/1471-2334-12-295","volume":"12","author":"J Barberan","year":"2012","unstructured":"Barberan J, Alcazar B, Malmierca E, et al. Repeated Aspergillus isolation in respiratory samples from non-immunocompromised patients not selected based on clinical diagnoses: colonisation or infection? BMC Infect Dis Nov. 2012;12:12:295. https:\/\/doi.org\/10.1186\/1471-2334-12-295.","journal-title":"BMC Infect Dis Nov"},{"issue":"2","key":"189_CR68","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.resinv.2015.08.007","volume":"54","author":"S Ohara","year":"2016","unstructured":"Ohara S, Tazawa Y, Tanai C, et al. Clinical characteristics of patients with Aspergillus species isolation from respiratory samples: comparison of chronic pulmonary aspergillosis and colonization. Respir Investig Mar. 2016;54(2):92\u20137. https:\/\/doi.org\/10.1016\/j.resinv.2015.08.007.","journal-title":"Respir Investig Mar"},{"key":"189_CR69","doi-asserted-by":"publisher","unstructured":"Serrano R, Gimeno A, Plumed L et al. [Epidemiological profile and sensitivity pattern of isolates causing invasive fungal infection vs. colonizing isolates in non-neutropenic critically ill patients]. Rev Iberoam Micol. Perfil epidemiologico y patron de sensibilidad de aislamientos causantes de infeccion fungica invasora frente a aislamientos fungicos de colonizacion en pacientes criticos no neutropenicos. Jan 3. 2013;30(1):14\u201320. https:\/\/doi.org\/10.1016\/j.riam.2012.06.003","DOI":"10.1016\/j.riam.2012.06.003"},{"issue":"121","key":"189_CR70","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1183\/09059180.00001011","volume":"1","author":"M Kousha","year":"2011","unstructured":"Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev Sep. 2011;1(121):156\u201374. https:\/\/doi.org\/10.1183\/09059180.00001011.","journal-title":"Eur Respir Rev Sep"},{"issue":"3","key":"189_CR71","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1086\/509917","volume":"1","author":"RE Greene","year":"2007","unstructured":"Greene RE, Schlamm HT, Oestmann JW, et al. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis Feb. 2007;1(3):373\u20139. https:\/\/doi.org\/10.1086\/509917.","journal-title":"Clin Infect Dis Feb"},{"key":"189_CR72","doi-asserted-by":"publisher","unstructured":"Candel FJ, Salavert M, Estella A, et al. Ten issues to update in nosocomial or hospital-acquired pneumonia: an expert review. J Clin Med Oct. 2023;14(20). https:\/\/doi.org\/10.3390\/jcm12206526.","DOI":"10.3390\/jcm12206526"},{"issue":"10","key":"189_CR73","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1473-3099(05)70238-3","volume":"5","author":"WW Hope","year":"2005","unstructured":"Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis Oct. 2005;5(10):609\u201322. https:\/\/doi.org\/10.1016\/S1473-3099(05)70238-3.","journal-title":"Lancet Infect Dis Oct"},{"issue":"6","key":"189_CR74","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1309\/EXBV-YAUP-ENBM-285Y","volume":"119","author":"JJ Tarrand","year":"2003","unstructured":"Tarrand JJ, Lichterfeld M, Warraich I, et al. Diagnosis of invasive septate mold infections. A correlation of Microbiological culture and histologic or cytologic examination. Am J Clin Pathol Jun. 2003;119(6):854\u20138. https:\/\/doi.org\/10.1309\/EXBV-YAUP-ENBM-285Y.","journal-title":"Am J Clin Pathol Jun"},{"issue":"5","key":"189_CR75","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1086\/432470","volume":"1","author":"L Ostrosky-Zeichner","year":"2005","unstructured":"Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1\u2013>3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis Sep. 2005;1(5):654\u20139. https:\/\/doi.org\/10.1086\/432470.","journal-title":"Clin Infect Dis Sep"},{"issue":"1","key":"189_CR76","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1128\/JCM.43.1.299-305.2005","volume":"43","author":"C Pazos","year":"2005","unstructured":"Pazos C, Ponton J, Del Palacio A. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for Circulating Galactomannan. J Clin Microbiol Jan. 2005;43(1):299\u2013305. https:\/\/doi.org\/10.1128\/JCM.43.1.299-305.2005.","journal-title":"J Clin Microbiol Jan"},{"issue":"1","key":"189_CR77","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","volume":"1","author":"W Meersseman","year":"2008","unstructured":"Meersseman W, Lagrou K, Maertens J, et al. Galactomannan in Bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med Jan. 2008;1(1):27\u201334. https:\/\/doi.org\/10.1164\/rccm.200704-606OC.","journal-title":"Am J Respir Crit Care Med Jan"},{"key":"189_CR78","doi-asserted-by":"publisher","unstructured":"Scharmann U, Verhasselt HL, Kirchhoff L, Furnica DT, Steinmann J, Rath PM. Microbiological non-culture-based methods for diagnosing invasive pulmonary aspergillosis in ICU patients. Diagnostics (Basel) Aug. 2023;21(16). https:\/\/doi.org\/10.3390\/diagnostics13162718.","DOI":"10.3390\/diagnostics13162718"},{"key":"189_CR79","doi-asserted-by":"publisher","unstructured":"Townsend L, Martin-Loeches I. Invasive aspergillosis in the intensive care unit. Diagnostics (Basel) Nov. 2022;6(11). https:\/\/doi.org\/10.3390\/diagnostics12112712.","DOI":"10.3390\/diagnostics12112712"},{"issue":"8","key":"189_CR80","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/mmy\/myz002","volume":"1","author":"M Mikulska","year":"2019","unstructured":"Mikulska M, Furfaro E, De Carolis E, et al. Use of Aspergillus fumigatus real-time PCR in Bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with Galactomannan. Med Mycol Nov. 2019;1(8):987\u201396. https:\/\/doi.org\/10.1093\/mmy\/myz002.","journal-title":"Med Mycol Nov"},{"issue":"4","key":"189_CR81","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s15010-025-02572-2","volume":"53","author":"D Wichmann","year":"2025","unstructured":"Wichmann D, Hoenigl M, Koehler P, et al. Diagnosis and treatment of invasive pulmonary aspergillosis in critically ill intensive care patients: executive summary of the German National guideline (AWMF 113-005). Infection Aug. 2025;53(4):1299\u2013310. https:\/\/doi.org\/10.1007\/s15010-025-02572-2.","journal-title":"Infection Aug"},{"key":"189_CR82","doi-asserted-by":"publisher","unstructured":"Patterson TF, Thompson GR 3rd, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America. Clin Infect Dis Aug. 2016;15(4):e1\u201360. https:\/\/doi.org\/10.1093\/cid\/ciw326.","DOI":"10.1093\/cid\/ciw326"},{"issue":"3","key":"189_CR83","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/03602532.2019.1632888","volume":"51","author":"J Schulz","year":"2019","unstructured":"Schulz J, Kluwe F, Mikus G, Michelet R, Kloft C. Novel insights into the complex pharmacokinetics of voriconazole: a review of its metabolism. Drug Metab Rev Aug. 2019;51(3):247\u201365. https:\/\/doi.org\/10.1080\/03602532.2019.1632888.","journal-title":"Drug Metab Rev Aug"},{"key":"189_CR84","doi-asserted-by":"publisher","first-page":"1292163","DOI":"10.3389\/fphar.2024.1292163","volume":"15","author":"BN Huo","year":"2024","unstructured":"Huo BN, Shu L, Xiao JW, et al. Clinical drug interactions between voriconazole and 38 other drugs: a retrospective analysis of adverse events. Front Pharmacol. 2024;15:1292163. https:\/\/doi.org\/10.3389\/fphar.2024.1292163.","journal-title":"Front Pharmacol"},{"key":"189_CR85","doi-asserted-by":"publisher","unstructured":"Lewis JS 2nd, Wiederhold NP, Hakki M, Thompson GR 3. New perspectives on antimicrobial agents: isavuconazole. Antimicrob Agents Chemother Sep. 2022;20(9):e0017722. https:\/\/doi.org\/10.1128\/aac.00177-22.","DOI":"10.1128\/aac.00177-22"},{"issue":"4","key":"189_CR86","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.riam.2018.04.003","volume":"35","author":"JR Azanza Perea","year":"2018","unstructured":"Azanza Perea JR, Sadaba Diaz de Rada B. [Pharmacological profile of isavuconazole]. Rev Iberoam Micol Oct-Dec. 2018;35(4):186\u201391. https:\/\/doi.org\/10.1016\/j.riam.2018.04.003. Perfil farmacologico del isavuconazol.","journal-title":"Rev Iberoam Micol Oct-Dec"},{"key":"189_CR87","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2147\/IDR.S102207","volume":"9","author":"SK Natesan","year":"2016","unstructured":"Natesan SK, Chandrasekar PH. Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations. Infect Drug Resist. 2016;9:291\u2013300. https:\/\/doi.org\/10.2147\/IDR.S102207.","journal-title":"Infect Drug Resist"},{"issue":"10","key":"189_CR88","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1086\/514341","volume":"15","author":"OA Cornely","year":"2007","unstructured":"Cornely OA, Maertens J, Bresnik M, et al. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis May. 2007;15(10):1289\u201397. https:\/\/doi.org\/10.1086\/514341.","journal-title":"Clin Infect Dis May"},{"issue":"11","key":"189_CR89","doi-asserted-by":"publisher","first-page":"6879","DOI":"10.1128\/AAC.03777-14","volume":"58","author":"MJ Dolton","year":"2014","unstructured":"Dolton MJ, Bruggemann RJ, Burger DM, McLachlan AJ. Understanding variability in posaconazole exposure using an integrated population Pharmacokinetic analysis. Antimicrob Agents Chemother Nov. 2014;58(11):6879\u201385. https:\/\/doi.org\/10.1128\/AAC.03777-14.","journal-title":"Antimicrob Agents Chemother Nov"},{"issue":"2","key":"189_CR90","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7326\/M13-2508","volume":"20","author":"KA Marr","year":"2015","unstructured":"Marr KA, Schlamm HT, Herbrecht R, et al. Combination antifungal therapy for invasive aspergillosis: a randomized trial. Ann Intern Med. Jan 2015;20(2):81\u20139. https:\/\/doi.org\/10.7326\/M13-2508.","journal-title":"Ann Intern Med"},{"issue":"6","key":"189_CR91","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1093\/jac\/dku023","volume":"69","author":"M Siopi","year":"2014","unstructured":"Siopi M, Mavridou E, Mouton JW, Verweij PE, Zerva L, Meletiadis J. Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic\/pharmacodynamic model. J Antimicrob Chemother Jun. 2014;69(6):1611\u20139. https:\/\/doi.org\/10.1093\/jac\/dku023.","journal-title":"J Antimicrob Chemother Jun"},{"key":"189_CR92","doi-asserted-by":"publisher","unstructured":"Garcia-Vidal C, Alastruey-Izquierdo A, Aguilar-Guisado M et al. Oct. Executive summary of clinical practice guideline for the management of invasive diseases caused by aspergillus: 2018 update by the GEMICOMED-SEIMC\/REIPI. Enferm infecc microbiol clin (Engl Ed). 2019;37(8):535\u201341. https:\/\/doi.org\/10.1016\/j.eimc.2018.03.018","DOI":"10.1016\/j.eimc.2018.03.018"},{"issue":"2","key":"189_CR93","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s00134-025-07793-5","volume":"51","author":"JA Roberts","year":"2025","unstructured":"Roberts JA, Sime FB, Lipman J, et al. Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for screening antifungal exposure in intensive care Units-the SAFE-ICU study. Intensive Care Med Feb. 2025;51(2):302\u201317. https:\/\/doi.org\/10.1007\/s00134-025-07793-5.","journal-title":"Intensive Care Med Feb"},{"issue":"Spec 1","key":"189_CR94","first-page":"14","volume":"21","author":"M Sa Borges","year":"2008","unstructured":"Sa Borges M. Up-date on the treatment of serious fungal infections. Rev Esp Quimioter. 2008;21(Spec 1):14\u201325. Actualizacion sobre el tratamiento de las infecciones fungicas graves.","journal-title":"Rev Esp Quimioter"},{"key":"189_CR95","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ijid.2014.07.007","volume":"28","author":"AA Panackal","year":"2014","unstructured":"Panackal AA, Parisini E, Proschan M. Salvage combination antifungal therapy for acute invasive aspergillosis May improve outcomes: a systematic review and meta-analysis. Int J Infect Dis Nov. 2014;28:80\u201394. https:\/\/doi.org\/10.1016\/j.ijid.2014.07.007.","journal-title":"Int J Infect Dis Nov"}],"container-title":["Pneumonia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41479-025-00189-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41479-025-00189-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41479-025-00189-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T01:02:19Z","timestamp":1772586139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41479-025-00189-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["189"],"URL":"https:\/\/doi.org\/10.1186\/s41479-025-00189-5","relation":{},"ISSN":["2200-6133"],"issn-type":[{"value":"2200-6133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The incorrect affiliation 4 was given in the published article due to an error by the publisher, this article has been updated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CG-V has received honoraria for talks on behalf of Gilead Science, MSD, Pfizer, Shionogi, AbbVie, Advanz Pharma, and a grant support from Gilead Science, and Mudipharma. AS has received honoraria for talks and advisory boards from Merck Sharp and Dohme, Pfizer, Shionogi, Novartis, Angelini and Menarini as well as grant support from Pfizer and Gilead Sciences.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}